Glenmark and Helsinn Group’s exclusive licensing deal for launch of Akynzeo in India and Nepal
Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, and Helsinn Group (“Helsinn”), a Swiss pharmaceutical group focused on building quality cancer... Read More